Mulberry compounds demonstrate potential to alter gut microbiota and metabolic function in preliminary studies
Research indicates that bioactive compounds found in mulberry leaves and fruit, particularly polyphenols and polysaccharides, may modify the gut microbiome composition in ways that support metabolic health. Effects vary considerably based on mulberry species, plant part used, and preparation method, though human clinical trials are needed to validate these promising findings observed in animal models.
Mulberry plants produce different beneficial compounds depending on their species and which parts are harvested. White mulberry leaves contain a compound called 1-deoxynojirimycin that influences how the body processes carbohydrates, while black mulberry fruit is rich in anthocyanins and other protective plant chemicals. The preparation method—whether leaves are dried, fermented, or extracted with specific solvents—substantially alters which compounds remain active and available to interact with gut bacteria.
When gut microbes break down mulberry compounds, they generate short-chain fatty acids including butyrate and propionate, which support intestinal health and may influence how the body regulates blood sugar and fat metabolism. Laboratory studies in animals have shown that certain mulberry preparations shift the balance of bacterial populations toward beneficial species, though the specific effects depend on both the plant material's composition and the extraction technique used.
These findings could interest food researchers, supplement manufacturers, and individuals managing metabolic health concerns, as they suggest mulberry-derived products might offer functional food applications. However, the lack of human clinical evidence means any health claims remain preliminary. Future research may determine whether these compounds provide meaningful benefits in real-world settings, potentially informing dietary recommendations or therapeutic development, though regulatory bodies would require rigorous human trials before approving specific health claims.